231 related articles for article (PubMed ID: 31259422)
1. The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.
Reader CS; Vallath S; Steele CW; Haider S; Brentnall A; Desai A; Moore KM; Jamieson NB; Chang D; Bailey P; Scarpa A; Lawlor R; Chelala C; Keyse SM; Biankin A; Morton JP; Evans TJ; Barry ST; Sansom OJ; Kocher HM; Marshall JF
J Pathol; 2019 Nov; 249(3):332-342. PubMed ID: 31259422
[TBL] [Abstract][Full Text] [Related]
2. Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch.
Tod J; Hanley CJ; Morgan MR; Rucka M; Mellows T; Lopez MA; Kiely P; Moutasim KA; Frampton SJ; Sabnis D; Fine DR; Johnson C; Marshall JF; Scita G; Jenei V; Thomas GJ
J Pathol; 2017 Sep; 243(1):37-50. PubMed ID: 28608476
[TBL] [Abstract][Full Text] [Related]
3. Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.
Moore KM; Desai A; Delgado BL; Trabulo SMD; Reader C; Brown NF; Murray ER; Brentnall A; Howard P; Masterson L; Zammarchi F; Hartley JA; van Berkel PH; Marshall JF
Theranostics; 2020; 10(7):2930-2942. PubMed ID: 32194845
[No Abstract] [Full Text] [Related]
4. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
5. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
Man YKS; Davies JA; Coughlan L; Pantelidou C; Blázquez-Moreno A; Marshall JF; Parker AL; Halldén G
Mol Cancer Ther; 2018 Feb; 17(2):575-587. PubMed ID: 29367266
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of integrin αvβ6 in breast cancer.
Moore KM; Thomas GJ; Duffy SW; Warwick J; Gabe R; Chou P; Ellis IO; Green AR; Haider S; Brouilette K; Saha A; Vallath S; Bowen R; Chelala C; Eccles D; Tapper WJ; Thompson AM; Quinlan P; Jordan L; Gillett C; Brentnall A; Violette S; Weinreb PH; Kendrew J; Barry ST; Hart IR; Jones JL; Marshall JF
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24974129
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
Moutasim KA; Mellows T; Mellone M; Lopez MA; Tod J; Kiely PC; Sapienza K; Greco A; Neill GW; Violette S; Weinreb PH; Marshall JF; Ottensmeier CH; Sayan AE; Jenei V; Thomas GJ
J Pathol; 2014 Jun; 233(2):196-208. PubMed ID: 24573955
[TBL] [Abstract][Full Text] [Related]
10. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
13. A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo.
Eberlein C; Kendrew J; McDaid K; Alfred A; Kang JS; Jacobs VN; Ross SJ; Rooney C; Smith NR; Rinkenberger J; Cao A; Churchman A; Marshall JF; Weir HM; Bedian V; Blakey DC; Foltz IN; Barry ST
Oncogene; 2013 Sep; 32(37):4406-16. PubMed ID: 23108397
[TBL] [Abstract][Full Text] [Related]
14. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
[TBL] [Abstract][Full Text] [Related]
15. Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer.
Tummers WS; Kimura RH; Abou-Elkacem L; Beinat C; Vahrmeijer AL; Swijnenburg RJ; Willmann JK; Gambhir SS
Clin Cancer Res; 2018 Apr; 24(7):1667-1676. PubMed ID: 29298796
[No Abstract] [Full Text] [Related]
16. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.
Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M
J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.
Ueda M; Fukushima T; Ogawa K; Kimura H; Ono M; Yamaguchi T; Ikehara Y; Saji H
Biochem Biophys Res Commun; 2014 Mar; 445(3):661-6. PubMed ID: 24583127
[TBL] [Abstract][Full Text] [Related]
18. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL
Clin Cancer Res; 2014 Jan; 20(2):344-57. PubMed ID: 24150233
[TBL] [Abstract][Full Text] [Related]
19. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
20. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
